Related Experiment Video
Updated: Apr 12, 2026
Laser-Induced Chronic Ocular Hypertension Model on SD Rats
Published on: December 4, 2007
Recent developments in laser treatment of diabetic retinopathy
1Department of Ophthalmology and Visual Sciences, Yale School of Medicine, New Haven, CT 06511, USA.
Abstract:
Laser photocoagulation has been the mainstay of diabetic retinopathy treatment since its development in mid-20(th) century. With the advent of antivascular endothelial growth factor therapy, the role of laser therapy appeared to be diminished, however many advances in laser technology have been developed since. This review will describe recent advances in laser treatment of diabetic retinopathy including pattern scan laser, short-pulse duration and a reduced fluence laser, and navigated laser system for proliferative diabetic retinopathy and macular edema.
Insights
Recent advances in laser therapy offer new hope for treating diabetic retinopathy (DR). Innovations like pattern scan laser and navigated systems are improving outcomes for proliferative DR and macular edema.
Area of Science:
- Ophthalmology
- Medical Technology
- Diabetic Retinopathy Research
Background:
- Laser photocoagulation has historically been a primary treatment for diabetic retinopathy (DR).
- The emergence of anti-vascular endothelial growth factor (anti-VEGF) therapies seemingly reduced the prominence of laser treatment.
- Significant technological advancements in laser therapy have occurred since its initial widespread adoption.
Purpose of the Study:
- To review recent innovations in laser treatment modalities for diabetic retinopathy.
- To highlight advancements applicable to proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME).
Main Methods:
- Review of recent literature on advanced laser technologies for diabetic retinopathy.
- Description of specific novel laser systems and their characteristics.
Main Results:
- Pattern scan laser (PASCAL) systems offer more precise and potentially less damaging retinal treatment.
- Short-pulse duration and reduced fluence laser applications aim to minimize collateral thermal damage.
- Navigated laser systems enhance treatment accuracy and reproducibility for complex cases of PDR and DME.
Conclusions:
- Despite the rise of anti-VEGF therapies, advanced laser techniques remain a vital component in managing diabetic retinopathy.
- New laser technologies provide refined options for treating proliferative diabetic retinopathy and diabetic macular edema.
- These innovations may offer improved safety profiles and efficacy in specific patient populations.
